These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31440081)

  • 1. MicroRNA 145 enhances chemosensitivity of glioblastoma stem cells to demethoxycurcumin.
    Qian C; Wang B; Zou Y; Zhang Y; Hu X; Sun W; Xiao H; Liu H; Shi L
    Cancer Manag Res; 2019; 11():6829-6840. PubMed ID: 31440081
    [No Abstract]   [Full Text] [Related]  

  • 2. Demethoxycurcumin was superior to temozolomide in the inhibition of the growth of glioblastoma stem cells in vivo.
    Leng L; Zhong X; Sun G; Qiu W; Shi L
    Tumour Biol; 2016 Oct; ():. PubMed ID: 27757851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demethoxycurcumin was prior to temozolomide on inhibiting proliferation and induced apoptosis of glioblastoma stem cells.
    Shi L; Fei X; Wang Z
    Tumour Biol; 2015 Sep; 36(9):7107-19. PubMed ID: 25877753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABCG2 downregulation in glioma stem cells enhances the therapeutic efficacy of demethoxycurcumin.
    Chen L; Shi L; Wang W; Zhou Y
    Oncotarget; 2017 Jun; 8(26):43237-43247. PubMed ID: 28591733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demethoxycurcumin analogue DMC-BH inhibits orthotopic growth of glioma stem cells by targeting JNK/ERK signaling.
    Shi L; Sun G; Zhu H
    Aging (Albany NY); 2020 Jul; 12(14):14718-14735. PubMed ID: 32710727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PI3K inhibitor combined with miR-125b inhibitor sensitize TMZ-induced anti-glioma stem cancer effects through inactivation of Wnt/β-catenin signaling pathway.
    Shi L; Fei X; Wang Z; You Y
    In Vitro Cell Dev Biol Anim; 2015 Nov; 51(10):1047-55. PubMed ID: 26170223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pterostilbene suppressed irradiation-resistant glioma stem cells by modulating GRP78/miR-205 axis.
    Huynh TT; Lin CM; Lee WH; Wu AT; Lin YK; Lin YF; Yeh CT; Wang LS
    J Nutr Biochem; 2015 May; 26(5):466-75. PubMed ID: 25736407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2.
    Luo W; Yan D; Song Z; Zhu X; Liu X; Li X; Zhao S
    Life Sci; 2019 Jun; 226():98-106. PubMed ID: 30980849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-146b-5p overexpression attenuates stemness and radioresistance of glioma stem cells by targeting HuR/lincRNA-p21/β-catenin pathway.
    Yang W; Yu H; Shen Y; Liu Y; Yang Z; Sun T
    Oncotarget; 2016 Jul; 7(27):41505-41526. PubMed ID: 27166258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-125b inhibitor may enhance the invasion-prevention activity of temozolomide in glioblastoma stem cells by targeting PIAS3.
    Shi L; Wan Y; Sun G; Zhang S; Wang Z; Zeng Y
    BioDrugs; 2014 Feb; 28(1):41-54. PubMed ID: 23857508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-Dose DMC Significantly Enhances the Effect of TMZ on Glioma Cells by Targeting Multiple Signaling Pathways Both In Vivo and In Vitro.
    Shi L; Sun G
    Neuromolecular Med; 2015 Dec; 17(4):431-42. PubMed ID: 26458914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of miR-181a suppresses the formation of glioblastoma stem cells by targeting the Notch2 oncogene and correlates with good prognosis in patients with glioblastoma multiforme.
    Huang SX; Zhao ZY; Weng GH; He XY; Wu CJ; Fu CY; Sui ZY; Ma YS; Liu T
    Biochem Biophys Res Commun; 2017 May; 486(4):1129-1136. PubMed ID: 28389242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-425-5p, a SOX2 target, regulates the expression of FOXJ3 and RAB31 and promotes the survival of GSCs.
    de la Rocha AMA; González-Huarriz M; Guruceaga E; Mihelson N; Tejada-Solís S; Díez-Valle R; Martínez-Vélez N; Fueyo J; Gomez-Manzano C; Alonso MM; Laterra J; López-Bertoni H
    Arch Clin Biomed Res; 2020; 4(3):221-238. PubMed ID: 32905473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IDH1 mutation diminishes aggressive phenotype in glioma stem cells.
    Yao Q; Cai G; Yu Q; Shen J; Gu Z; Chen J; Shi W; Shi J
    Int J Oncol; 2018 Jan; 52(1):270-278. PubMed ID: 29115585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DMC is not better than TMZ on intracranial anti-glioma effects.
    Shi L; Sun G
    J Cell Biochem; 2018 Jul; 119(7):6057-6064. PubMed ID: 29575236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-21 up-regulation mediates glioblastoma cancer stem cells apoptosis and proliferation by targeting FASLG.
    Shang C; Guo Y; Hong Y; Liu YH; Xue YX
    Mol Biol Rep; 2015 Mar; 42(3):721-7. PubMed ID: 25394756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FRAT1 Enhances the Proliferation and Tumorigenesis of CD133
    Guo G; Liu J; Ren Y; Mao X; Hao Y; Zhong C; Chen X; Wang X; Wu Y; Lian S; Mei L; Zhao Y
    J Cancer; 2020; 11(9):2421-2430. PubMed ID: 32201513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etoposide loaded layered double hydroxide nanoparticles reversing chemoresistance and eradicating human glioma stem cells in vitro and in vivo.
    Wang Z; Liang P; He X; Wu B; Liu Q; Xu Z; Wu H; Liu Z; Qian Y; Wang S; Zhu R
    Nanoscale; 2018 Jul; 10(27):13106-13121. PubMed ID: 29961791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
    Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
    J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glioma stem cells-derived exosomes promote the angiogenic ability of endothelial cells through miR-21/VEGF signal.
    Sun X; Ma X; Wang J; Zhao Y; Wang Y; Bihl JC; Chen Y; Jiang C
    Oncotarget; 2017 May; 8(22):36137-36148. PubMed ID: 28410224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.